ScreenPoint Medical Presents AI Application for Detecting Breast Cancer
By MedImaging International staff writers Posted on 28 Feb 2019 |
Image: The Transpara AI system automatically identifies soft-tissue and calcification lesions and combines the findings of all available views into a single cancer suspiciousness score (Photo courtesy of ScreenPoint Medical).
ScreenPoint Medical (Nijmegen, Netherlands) presented the latest version of its Transpara Artificial Intelligence (AI) system at ECR 2019 in Vienna.
ScreenPoint Medical develops image analysis technology for automated reading of mammograms and digital breast tomosynthesis exams, exploiting big data, deep learning and the latest developments in AI. The company’s Transpara processes 2D, 3D and combo mammography exams and is integrated in the workstations of an increasing number of OEM partners.
Utilizing state-of-the-art image analysis and deep learning technology, Transpara automatically identifies soft-tissue and calcification lesions and combines the findings of all available views into a single cancer suspiciousness score. Breast imaging professionals can use this Transpara Score to automatically identify exams that are highly likely to be normal and the exams with features indicating highly increased risk of cancer. Interactive decision support is provided to improve assessment of lesions. Information is provided concurrent during reading and only when needed, as a result of which, it does not slow down reading.
Transpara is the first AI application for detecting breast cancer in screening mammograms to gain 510(k) Clearance from the FDA, based on its unique functionality, which interactively provides support for detection and diagnosis. The clearance was supported by the results of a multi-reader, multi-case Reader Study, which demonstrated that radiologists significantly improved detection accuracy when using Transpara for decision support without increasing reading times. In the study, the stand-alone sensitivity and specificity of Transpara was nearly at the same level as that of radiologists.
ScreenPoint Medical develops image analysis technology for automated reading of mammograms and digital breast tomosynthesis exams, exploiting big data, deep learning and the latest developments in AI. The company’s Transpara processes 2D, 3D and combo mammography exams and is integrated in the workstations of an increasing number of OEM partners.
Utilizing state-of-the-art image analysis and deep learning technology, Transpara automatically identifies soft-tissue and calcification lesions and combines the findings of all available views into a single cancer suspiciousness score. Breast imaging professionals can use this Transpara Score to automatically identify exams that are highly likely to be normal and the exams with features indicating highly increased risk of cancer. Interactive decision support is provided to improve assessment of lesions. Information is provided concurrent during reading and only when needed, as a result of which, it does not slow down reading.
Transpara is the first AI application for detecting breast cancer in screening mammograms to gain 510(k) Clearance from the FDA, based on its unique functionality, which interactively provides support for detection and diagnosis. The clearance was supported by the results of a multi-reader, multi-case Reader Study, which demonstrated that radiologists significantly improved detection accuracy when using Transpara for decision support without increasing reading times. In the study, the stand-alone sensitivity and specificity of Transpara was nearly at the same level as that of radiologists.
Latest ECR 2019 News
- PaxeraHealth Showcases Advanced Image Sharing Platform at ECR
- iCAD Presents Latest AI Solution for Digital Breast Tomosynthesis
- Philips Introduces Software to Support Diagnostic Confidence
- Canon Medical Systems Showcases Wide Product Lineup in Vienna
- Radcal Demonstrates New Stand-Alone System at Imaging Trade Fair
- Fujifilm Medical Systems Europe Highlights AI Initiative in Austria
- SuperSonic Imagine Introduces Ultrasound System at ECR
- Esaote Presents Latest Ultrasound Technologies and AI-based Solutions at ECR
- Agfa HealthCare Demonstrates Enterprise Imaging and DR at ECR Trade Show
- Carestream Health Exhibits Advanced Imaging and IT Platforms in Austria
- Guerbet Displays New Multi-Use Injector at ECR 2019
- Shimadzu Europa Demonstrates Diagnostic Imaging and Analytical Technologies
- Barco Presents Latest Displays at 2019 European Congress of Radiology
- EIZO Presents New Radiological Monitor Solutions at Vienna Trade Fair
- Konica Minolta Presents Mobile Innovations at ECR